Skip to content
Home/Companies/Biotech/Biocrates
Biocrates

Biocrates

Biotech·Austria·Exited 2025·Held 6yr
Entry
2019
Hold
6yr
Exit
2025

Who owns Biocrates?

Biocrates was owned by MIG Capital through MIG Fonds 16 (2019 vintage) from 2019 to 2025, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-07

MIG Capital
Investor
MIG Capital
MIG Fonds 16 · 2019 · Evergreen

Key facts

HQAustria
SectorBiotech
StatusAcquired
Websitebiocrates.com
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2025

More from MIG Fonds 16

Other portfolio companies in the same fund.

mbiomics
mbiomics
Active
BiotechGermany· 2023
Inbolt
Inbolt
Active
Deep TechFrance· 2022
iOmx Therapeutics
iOmx Therapeutics
Active
BiotechGermany· 2021
Mimi Hearing Technologies
Mimi Hearing Technologies
Active
IndustrialsGermany· 2021
Zadient Technologies
Zadient Technologies
Active
Deep TechFrance· 2021
Innatera
Innatera
Active
Deep TechNetherlands· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Biocrates

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Biocrates?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Biocrates.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue